Cargando…

The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis

Endocrine cancers are a heterogeneous group of diseases that may arise from endocrine cells in any gland of the endocrine system. These malignancies may show an aggressive behavior and resistance to the common anticancer therapies. The etiopathogenesis of these tumors remains mostly unknown. The nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malaguarnera, Roberta, Morcavallo, Alaide, Belfiore, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423951/ https://www.ncbi.nlm.nih.gov/pubmed/22927847 http://dx.doi.org/10.1155/2012/635614

Ejemplares similares

Ligand-Mediated Endocytosis and Trafficking of the Insulin-Like Growth Factor Receptor I and Insulin Receptor Modulate Receptor Function
por: Morcavallo, Alaide, et al.
Publicado: (2014)

Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
por: Malaguarnera, Roberta, et al.
Publicado: (2015)

Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer
por: Buraschi, Simone, et al.
Publicado: (2020)

Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells
por: De Marco, Paola, et al.
Publicado: (2015)

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
por: Vella, Veronica, et al.
Publicado: (2019)

The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
por: Malaguarnera, Roberta, et al.
Publicado: (2014)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
por: Belfiore, A., et al.
Publicado: (2009)

The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
por: Malaguarnera, Roberta, et al.
Publicado: (2017)

Obesity, Diabetes, and Cancer: The Role of the Insulin/IGF Axis; Mechanisms and Clinical Implications
por: Morrione, Andrea, et al.
Publicado: (2022)

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway
por: Matà, Roberta, et al.
Publicado: (2015)

Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2010)

Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
por: Fruci, Barbara, et al.
Publicado: (2013)

Endocrine and Local IGF-I in the Bony Fish Immune System
por: Franz, Anne-Constance, et al.
Publicado: (2016)

Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
por: Vella, Veronica, et al.
Publicado: (2023)

Werner et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2010)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

The Role of Metformin in the Management of NAFLD
por: Mazza, Angela, et al.
Publicado: (2012)

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: Bertino, Gaetano, et al.
Publicado: (2014)

The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change
por: Janssen, Joseph A. M. J. L.
Publicado: (2023)

The Diseases of the Endocrine Glands
Publicado: (1935)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

A novel role for drebrin in regulating progranulin bioactivity in bladder cancer
por: Xu, Shi-Qiong, et al.
Publicado: (2015)

Human conditions of insulin-like growth factor-I (IGF-I) deficiency
por: Puche, Juan E, et al.
Publicado: (2012)

Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
por: Shrestha, Sumana, et al.
Publicado: (2021)

Grand Challenges in Cancer Endocrinology: Endocrine Related Cancers, an Expanding Concept
por: Belfiore, Antonino, et al.
Publicado: (2013)

The Role of the Endocrine Glands in Ketosis—I. The Ketosis of Fasting
por: Amatruda, Thomas T., et al.
Publicado: (1959)

The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018)

IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor
por: Versteyhe, Soetkin, et al.
Publicado: (2013)

Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells
por: Vella, Veronica, et al.
Publicado: (2017)

Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway
por: Thordarson, Gudmundur, et al.
Publicado: (2004)

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands
por: Egalini, Filippo, et al.
Publicado: (2022)

The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling
por: Okuyama, Tomoko, et al.
Publicado: (2021)

IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
por: Belfiore, Antonino, et al.
Publicado: (2023)

Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)

Insulin/IGF-I and Related Signaling Pathways Regulate Aging in Nondividing Cells: from Yeast to the Mammalian Brain
por: Parrella, Edoardo, et al.
Publicado: (2010)

Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System
por: Vella, Veronica, et al.
Publicado: (2021)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0lsgdgko93612s4ss06uqkbm6i